Results 171 to 180 of about 51,667 (257)
The recurrence of osteoporotic fractures among first- and second-generation immigrants in Sweden. [PDF]
Wändell P +5 more
europepmc +1 more source
ABSTRACT Background Testosterone deficiency is highly prevalent in men with chronic spinal cord injury (SCI) and is associated with obesity, sarcopenia, systemic inflammation, and metabolic dysfunction. However, the independent prognostic role of low testosterone in long‐term mortality in this population remains unclear.
D. Tienforti +8 more
wiley +1 more source
Associations of muscle strength and functional power with longitudinal change in HR-pQCT bone parameters: the Osteoporotic Fractures in Men (MrOS) Study. [PDF]
Heilmann NZ +12 more
europepmc +1 more source
Key demographic, biological, and material considerations that drive the need for advanced injectable bone cement technologies. Injectable bone cements (IBCs) are widely used in orthopaedic and craniofacial applications due to their minimally invasive delivery and ability to provide early mechanical stabilisation.
Frank Fei +2 more
wiley +1 more source
Should we consider ankle fractures as osteoporotic fractures? [PDF]
Falk SSI, Mittlmeier T.
europepmc +1 more source
ABSTRACT Childhood‐onset multisystem Langerhans cell histiocytosis can lead to delayed adult morbidity involving the neurologic, hypothalamic–pituitary, and skeletal systems. Progressive cerebellar dysfunction, chronic pituitary insufficiency, and severe skeletal fragility may emerge years after apparent disease control, underscoring the need for ...
Suhaib Alnahar +4 more
wiley +1 more source
Osteoporotic spinal fractures: diagnosis and treatment. [PDF]
Aim: The aim of this paper is to analyse the literature findings on osteoporotic vertebral fractures, provide reliable evidence on effective treatment strategies for osteoporotic vertebral fractures, and to describe a series of clinical cases ...
Riabec, Pavel,
core
The Osteoporotic Fractures in Men study (MrOS): a 25-yr landmark study of skeletal health in older men. [PDF]
Cauley JA +10 more
europepmc +1 more source
Discontinuing Long‐Term Denosumab in Treating Fragile Bone: Why, for Whom, and How?
Discontinuation of denosumab (Dmab) may be necessary due to adverse events or an unfavorable long‐term risk–benefit profile. However, accumulating evidence demonstrates pronounced rebound phenomena after withdrawal, most notably a marked increase in multiple vertebral fractures, and, in some reports, elevated mortality.
Ko‐Hsiu Lu +5 more
wiley +1 more source
Osteoporotic fractures prediction in Chinese postmenopausal women: a machine learning-based multi-dimensional approach. [PDF]
Zhu W +7 more
europepmc +1 more source

